0001062993-25-001748.txt : 20250205 0001062993-25-001748.hdr.sgml : 20250205 20250205172133 ACCESSION NUMBER: 0001062993-25-001748 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250205 DATE AS OF CHANGE: 20250205 EFFECTIVENESS DATE: 20250205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KisoTerra Biotech Corp. CENTRAL INDEX KEY: 0001754473 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-537476 FILM NUMBER: 25594458 BUSINESS ADDRESS: STREET 1: 1090 HOMER STREET STREET 2: SUITE 300 CITY: VANCOUVER STATE: A1 ZIP: V6B 2W9 BUSINESS PHONE: 6042606944 MAIL ADDRESS: STREET 1: 1090 HOMER STREET STREET 2: SUITE 300 CITY: VANCOUVER STATE: A1 ZIP: V6B 2W9 FORMER COMPANY: FORMER CONFORMED NAME: KISOLITE CORP. DATE OF NAME CHANGE: 20180927 D 1 primary_doc.xml X0708 D LIVE 0001754473 KisoTerra Biotech Corp. 1090 HOMER STREET SUITE 300 VANCOUVER A1 BRITISH COLUMBIA, CANADA V6B 2W9 6042606944 CANADA (FEDERAL LEVEL) KISOLITE CORP. Corporation true Brent Hunter 1090 Homer Street Suite 300 Vancouver A1 BRITISH COLUMBIA, CANADA V6B 2W9 Executive Officer Corporate Secretary Michael Stocker 1090 Homer Street Suite 300 Vancouver A1 BRITISH COLUMBIA, CANADA V6B 2W9 Director Josef Reschreiter 1090 Homer Street Suite 300 Vancouver A1 BRITISH COLUMBIA, CANADA V6B 2W9 Executive Officer Director President, Chief Executive Officer and Chairman Dirk Lange 1090 Homer Street Suite 300 Vancouver A1 BRITISH COLUMBIA, CANADA V6B 2W9 Executive Officer Chief Scientific Officer David Work 1090 Homer Street Suite 300 Vancouver A1 BRITISH COLUMBIA, CANADA V6B 2W9 Director Rich Frontain 1090 Homer Street Suite 300 Vancouver A1 BRITISH COLUMBIA, CANADA V6B 2W9 Director Neil Branda 1090 Homer Street Suite 300 Vancouver A1 BRITISH COLUMBIA, CANADA V6B 2W9 Executive Officer Director Chief Technology Officer Douglas Frankiw 1090 Homer Street Suite 300 Vancouver A1 BRITISH COLUMBIA, CANADA V6B 2W9 Director Other Decline to Disclose 06b false 2025-01-31 false true true Common Shares. false 0 24165 24165 0 Total Offering Amount represents price of 100,000 common shares sold at CAD$0.35 converted to USD. false 1 0 0 0 false KisoTerra Biotech Corp. /s/ Brent Hunter Brent Hunter Corporate Secretary 2025-02-04